7,215 Shares in Doximity, Inc. (NASDAQ:DOCS) Bought by Commerce Bank

Commerce Bank bought a new position in shares of Doximity, Inc. (NASDAQ:DOCS) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 7,215 shares of the company’s stock, valued at approximately $314,000.

Several other institutional investors and hedge funds have also bought and sold shares of DOCS. CANADA LIFE ASSURANCE Co boosted its stake in Doximity by 22.7% during the first quarter. CANADA LIFE ASSURANCE Co now owns 80,464 shares of the company’s stock worth $2,165,000 after acquiring an additional 14,862 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its stake in shares of Doximity by 0.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 559,826 shares of the company’s stock valued at $15,065,000 after buying an additional 2,190 shares in the last quarter. Comerica Bank lifted its stake in shares of Doximity by 4.1% in the first quarter. Comerica Bank now owns 63,704 shares of the company’s stock valued at $1,714,000 after buying an additional 2,480 shares in the last quarter. iA Global Asset Management Inc. lifted its stake in shares of Doximity by 28.2% in the first quarter. iA Global Asset Management Inc. now owns 32,737 shares of the company’s stock valued at $881,000 after buying an additional 7,208 shares in the last quarter. Finally, Virtu Financial LLC bought a new position in shares of Doximity in the first quarter valued at $223,000. 87.19% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have weighed in on DOCS. Barclays raised their price objective on shares of Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a research note on Monday, November 11th. JPMorgan Chase & Co. raised their price objective on shares of Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a research note on Thursday, November 21st. Evercore ISI raised their price objective on shares of Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Baird R W raised shares of Doximity to a “strong-buy” rating in a research note on Tuesday, September 17th. Finally, Needham & Company LLC raised shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a research report on Friday, August 9th. Eleven equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $52.27.

Doximity Trading Down 0.2 %

DOCS stock opened at $53.44 on Thursday. The firm has a 50 day moving average of $45.10 and a 200-day moving average of $35.55. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $61.75. The firm has a market capitalization of $9.98 billion, a P/E ratio of 61.43, a price-to-earnings-growth ratio of 3.91 and a beta of 1.30.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.